Reaction Details Report a problem with these data
Target
GTPase HRas
Ligand
BDBM50060145
Substrate
n/a
Meas. Tech.
ChEMBL_76422 (CHEMBL685869)
IC50
300±n/a nM
Citation
 McNamara, DJ; Dobrusin, E; Leonard, DM; Shuler, KR; Kaltenbronn, JS; Quin, J; Bur, S; Thomas, CE; Doherty, AM; Scholten, JD; Zimmerman, KK; Gibbs, BS; Gowan, RC; Latash, MP; Leopold, WR; Przybranowski, SA; Sebolt-Leopold, JS C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice. J Med Chem 40:3319-22 (1997) [PubMed]  Article 
Target
Name:
GTPase HRas
Synonyms:
GTPase HRas, N-terminally processed | H-Ras | H-Ras-1 | HRAS | HRAS1 | Ha-Ras | His6-Ha-Ras-CVLS | RASH_HUMAN | Transforming protein p21 | Transforming protein p21/H-Ras-1 | Wild-type Ha-Ras | c-H-ras | p21ras
Type:
Other Protein Type
Mol. Mass.:
21293.37
Organism:
Homo sapiens (Human)
Description:
P01112
Residue:
189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS
  
Inhibitor
Name:
BDBM50060145
Synonyms:
CHEMBL115669 | [(S)-1-{(4-Benzyloxy-benzyl)-[((S)-2-phenyl-propylcarbamoyl)-methyl]-carbamoyl}-2-(3H-imidazol-4-yl)-ethyl]-carbamic acid benzyl ester
Type:
Small organic molecule
Emp. Form.:
C39H41N5O5
Mol. Mass.:
659.7733
SMILES:
C[C@H](CNC(=O)CN(Cc1ccc(OCc2ccccc2)cc1)C(=O)[C@H](Cc1cnc[nH]1)NC(=O)OCc1ccccc1)c1ccccc1
Structure:
Search PDB for entries with ligand similarity: